Profil
Nancy E.
Stagliano was the founder of CytomX Therapeutics, Inc. (2008) and True North Therapeutics, Inc. (2013) where the title held was Chief Executive Officer & Director.
Dr. Stagliano is also the founder of CytomX Therapeutics Holdings LLC.
Current jobs include Chairman & Co-Chief Executive Officer at Neuron23, Inc. (2020), Executive Chairman at Electra Therapeutics, Inc., Chairman at Star Therapeutics, Inc. (2018), Director at Pancreatic Cancer Action Network, Inc. (2020), and Independent Director at Pandion Operations, Inc. (2018).
Former jobs include Chief Executive Officer & Director at iPierian, Inc. (2011-2014), Associate Director-Discovery Strategy at Millennium Pharmaceuticals, Inc., Independent Director at biOasis Technologies, Inc. (2017-2019), Independent Director at Pandion Therapeutics, Inc., and Chief Operating Officer & VP-Development at CytomX LLC.
Education includes undergraduate and graduate degrees from Drexel University and a doctorate from the University of Miami.
Postes actifs de Nancy E. Stagliano
| Sociétés | Poste | Début |
|---|---|---|
Pandion Operations, Inc.
Pandion Operations, Inc. Miscellaneous Commercial ServicesCommercial Services Develops drugs for autoimmune, inflammatory and transplant indications | Directeur/Membre du Conseil | 26/07/2018 |
Neuron23, Inc.
Neuron23, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company that focuses on developing precision medicines for genetically defined neurological and immunological diseases | Directeur Général | 01/10/2020 |
Pancreatic Cancer Action Network, Inc.
Pancreatic Cancer Action Network, Inc. Medical/Nursing ServicesHealth Services Operates a charity which focuses on the early diagnosis of pancreatic cancer | Directeur/Membre du Conseil | 04/08/2020 |
Star Therapeutics, Inc.
Star Therapeutics, Inc. BiotechnologyHealth Technology Develops antibody therapies | Président | 01/06/2018 |
Electra Therapeutics, Inc.
Electra Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures therapies for immunological diseases and cancer | Président | - |
Anciens postes connus de Nancy E. Stagliano
| Sociétés | Poste | Fin |
|---|---|---|
| PANDION THERAPEUTICS, INC. | Directeur/Membre du Conseil | 01/04/2021 |
| BIOASIS TECHNOLOGIES INC. | Directeur/Membre du Conseil | 25/11/2019 |
True North Therapeutics, Inc.
True North Therapeutics, Inc. BiotechnologyHealth Technology Develops novel therapies that selectively inhibit the complement system to treat rare diseases | Fondateur | 01/06/2017 |
iPierian, Inc.
iPierian, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures biopharmaceutical products | Directeur Général | 01/04/2014 |
| ░░░░░░ ░░░ | ░░░░░░░░░ ░░░ ░░░░░░░░░░░ | ░░░░░░░░░░ |
Formation de Nancy E. Stagliano
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 15 |
|---|---|
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Health Technology |
Drexel University
Drexel University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Miami
University of Miami Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
biOasis Technologies, Inc.
biOasis Technologies, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops therapeutic drug delivery for the treatment of neurological diseases and disorders | Health Technology |
CytomX LLC
CytomX LLC Medical SpecialtiesHealth Technology Develops protein therapeutics and integrated medical diagnostic devices | Health Technology |
CytomX Therapeutics Holdings LLC
CytomX Therapeutics Holdings LLC Pharmaceuticals: MajorHealth Technology Engaged in the development of new generation targeted antibody therapeutics | Health Technology |
iPierian, Inc.
iPierian, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures biopharmaceutical products | Health Technology |
Pancreatic Cancer Action Network, Inc.
Pancreatic Cancer Action Network, Inc. Medical/Nursing ServicesHealth Services Operates a charity which focuses on the early diagnosis of pancreatic cancer | Health Services |
True North Therapeutics, Inc.
True North Therapeutics, Inc. BiotechnologyHealth Technology Develops novel therapies that selectively inhibit the complement system to treat rare diseases | Health Technology |
CytomX Therapeutics, Inc.
CytomX Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as an oncology-base biopharmaceutical company, which focuses on developing probody therapeutics for the treatment of cancer | Health Technology |
Pandion Operations, Inc.
Pandion Operations, Inc. Miscellaneous Commercial ServicesCommercial Services Develops drugs for autoimmune, inflammatory and transplant indications | Commercial Services |
Neuron23, Inc.
Neuron23, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company that focuses on developing precision medicines for genetically defined neurological and immunological diseases | Commercial Services |
Pandion Therapeutics, Inc.
Pandion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company which develops novel therapeutics for autoimmune diseases | Health Technology |
Electra Therapeutics, Inc.
Electra Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures therapies for immunological diseases and cancer | Health Technology |
Star Therapeutics, Inc.
Star Therapeutics, Inc. BiotechnologyHealth Technology Develops antibody therapies | Health Technology |
















